EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Prospects and challenges of neoantigen applications in oncology

Ranran Shi, Ling Ran, Yuan Tian, Wei Guo, Lifang Zhao, Shaoju Jin, Jiang Cheng, Zhe Zhang, Yongchao Ma

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.113329 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Ranran Shi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, Luohe Medical College, Luohe 462000, China; Henan Province Engineering & Technology Research Center of Foods fo…. Hauptthemen laut MEDLINE: Antigens, Neoplasm, Neoplasms, Cancer Vaccines, Tumor Microenvironment. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 139 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neoantigen, unique peptides resulting from tumor-specific mutations, represent a promising frontier in oncology for personalized cancer immunotherapy. Their unique features allow for the development of highly specific and effective cancer treatments, which can potentially overcome the limitations of conventional therapies. This paper explores the current prospects and challenges associated with the application of neoantigens in oncology. We examine the latest advances in neoantigen identification, vaccine development, and adoptive T cell therapy. Additionally, we discuss the obstacles related to neoantigen heterogeneity, immunogenicity prediction, and the tumor microenvironment. Through a comprehensive analysis of current research and clinical trials, this paper aims to provide a detailed overview of how neoantigens could revolutionize cancer treatment and the hurdles that must be overcome to realize their full potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, NeoplasmNeoplasmsCancer VaccinesTumor MicroenvironmentHumansAnimalsImmunotherapy, AdoptiveImmunotherapyVaccine DevelopmentPrecision Medicine

Stichwörter der Autor:innen

NeoantigenPersonalized therapyRegulatory challengesTumor heterogeneityTumor immunotherapy

Substanzen

Antigens, NeoplasmCancer Vaccines

Autor:innen und Institutionen

  • Department of Basic Medical Sciences, Luohe Medical College, Luohe 462000, China; Henan Province Engineering & Technology Research Center of Foods for Special Medical Purpose, Luohe Medical College, Luohe 462000, China.
  • Department of Basic Medical Sciences, Luohe Medical College, Luohe 462000, China.
  • Department of Basic Medical Sciences, Luohe Medical College, Luohe 462000, China; Department of Neurology, General Hospital of Ningxia Medical University, Yinchuan 750000, China.
  • School of Sciences, Henan University of Technology, Zhengzhou 450001, China. Electronic address: zhezhang@haut.edu.cn.
  • Department of Basic Medical Sciences, Luohe Medical College, Luohe 462000, China. Electronic address: 13839527381@163.com.

Zitieren

APA

Shi, R., Ran, L., Tian, Y., Guo, W., Zhao, L., Jin, S., Cheng, J., Zhang, Z., & Ma, Y. (2024). Prospects and challenges of neoantigen applications in oncology. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113329

Vancouver

Shi R, Ran L, Tian Y, Guo W, Zhao L, Jin S, et al. Prospects and challenges of neoantigen applications in oncology. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.113329

BibTeX
@article{Shi2024,
  author = {Shi, Ranran and Ran, Ling and Tian, Yuan and Guo, Wei and Zhao, Lifang and Jin, Shaoju and Cheng, Jiang and Zhang, Zhe and Ma, Yongchao},
  title = {Prospects and challenges of neoantigen applications in oncology},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.113329}
}
Kostenlos starten →